This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2017 Jun 13;317(22):2271.

doi: 10.1001/jama.2017.7153.

Amid FDA Approval Filings, Another CAR-T Therapy Patient Death

Jennifer Abbasi

PMID: 28609515
DOI: 10.1001/jama.2017.7153

Amid FDA Approval Filings, Another CAR-T Therapy Patient Death

Jennifer Abbasi. JAMA. 2017.

. 2017 Jun 13;317(22):2271.

doi: 10.1001/jama.2017.7153.

Author

Jennifer Abbasi

PMID: 28609515
DOI: 10.1001/jama.2017.7153

No abstract available

PubMed Disclaimer

Similar articles

The FDA, Juno Therapeutics, and the ethical imperative of transparency.
Hey SP, Kesselheim AS. Hey SP, et al. BMJ. 2016 Aug 15;354:i4435. doi: 10.1136/bmj.i4435. BMJ. 2016. PMID: 27526698 No abstract available.
[CAR-T immunotherapy, a regulatory milestone].
Jordan B. Jordan B. Med Sci (Paris). 2017 Nov;33(11):1003-1006. doi: 10.1051/medsci/20173311020. Epub 2017 Dec 4. Med Sci (Paris). 2017. PMID: 29200401 French.
First approval in sight for Novartis' CAR-T therapy after panel vote.
Sheridan C. Sheridan C. Nat Biotechnol. 2017 Aug 8;35(8):691-693. doi: 10.1038/nbt0817-691. Nat Biotechnol. 2017. PMID: 28787408 No abstract available.
Acute lymphoblastic leukaemia in 2017: Immunotherapy for ALL takes the world by storm.
Teachey DT, Hunger SP. Teachey DT, et al. Nat Rev Clin Oncol. 2018 Feb;15(2):69-70. doi: 10.1038/nrclinonc.2017.176. Epub 2017 Dec 19. Nat Rev Clin Oncol. 2018. PMID: 29255238 Review. No abstract available.
CD19 chimeric antigen receptor T cell therapy for the treatment of B cell lineage acute lymphoblastic leukemia.
Chen R, Song XT, Chen B. Chen R, et al. Discov Med. 2015 Oct;20(110):185-90. Discov Med. 2015. PMID: 26562471 Review.

See all similar articles

Cited by

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy.
Wang Z, Han W. Wang Z, et al. Biomark Res. 2018 Jan 22;6:4. doi: 10.1186/s40364-018-0116-0. eCollection 2018. Biomark Res. 2018. PMID: 29387417 Free PMC article. Review.
Utility of a safety switch to abrogate CD19.CAR T-cell-associated neurotoxicity.
Foster MC, Savoldo B, Lau W, Rubinos C, Grover N, Armistead P, Coghill J, Hagan RS, Morrison K, Buchanan FB, Cheng C, Laing S, Ivanova A, West J, Foster A, Serody J, Dotti G. Foster MC, et al. Blood. 2021 Jun 10;137(23):3306-3309. doi: 10.1182/blood.2021010784. Blood. 2021. PMID: 33624095 Free PMC article. Clinical Trial. No abstract available.
Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia.
An F, Wang H, Liu Z, Wu F, Zhang J, Tao Q, Li Y, Shen Y, Ruan Y, Zhang Q, Pan Y, Zhu W, Qin H, Wang Y, Fu Y, Feng Z, Zhai Z. An F, et al. Nat Commun. 2020 Nov 23;11(1):5928. doi: 10.1038/s41467-020-19774-x. Nat Commun. 2020. PMID: 33230103 Free PMC article. Clinical Trial.
Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics.
Runcie K, Budman DR, John V, Seetharamu N. Runcie K, et al. Mol Med. 2018 Sep 24;24(1):50. doi: 10.1186/s10020-018-0051-4. Mol Med. 2018. PMID: 30249178 Free PMC article. Review.
Chimeric antigen receptor modified T-cells for cancer treatment.
Han X, Wang Y, Han WD. Han X, et al. Chronic Dis Transl Med. 2018 Sep 18;4(4):225-243. doi: 10.1016/j.cdtm.2018.08.002. eCollection 2018 Dec. Chronic Dis Transl Med. 2018. PMID: 30603741 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations